153 related articles for article (PubMed ID: 16402633)
1. Evaluation of cytokine serum levels in patients with plaque-type psoriasis.
Roussaki-Schulze AV; Kouskoukis C; Petinaki E; Klimi E; Zafiriou E; Galanos A; Rallis E
Int J Clin Pharmacol Res; 2005; 25(4):169-73. PubMed ID: 16402633
[TBL] [Abstract][Full Text] [Related]
2. Ethanol enhances the IFN-gamma, TGF-alpha and IL-6 secretion in psoriatic co-cultures.
Ockenfels HM; Keim-Maas C; Funk R; Nussbaum G; Goos M
Br J Dermatol; 1996 Nov; 135(5):746-51. PubMed ID: 8977675
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.
Arican O; Aral M; Sasmaz S; Ciragil P
Mediators Inflamm; 2005 Oct; 2005(5):273-9. PubMed ID: 16258194
[TBL] [Abstract][Full Text] [Related]
4. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis.
Gomi T; Shiohara T; Munakata T; Imanishi K; Nagashima M
Arch Dermatol; 1991 Jun; 127(6):827-30. PubMed ID: 1903629
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
7. Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations.
Kastelan D; Kastelan M; Massari LP; Korsic M
Med Hypotheses; 2006; 67(6):1403-5. PubMed ID: 16844318
[TBL] [Abstract][Full Text] [Related]
8. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
9. Circulating cytokine levels compared to pain in patients with fibromyalgia -- a prospective longitudinal study over 6 months.
Wang H; Moser M; Schiltenwolf M; Buchner M
J Rheumatol; 2008 Jul; 35(7):1366-70. PubMed ID: 18528959
[TBL] [Abstract][Full Text] [Related]
10. Influence of psoriatic peripheral blood CD4+ T and CD8+ T lymphocytes on C-myc, Bcl-xL and Ki67 gene expression in keratinocytes.
Li X; Fan X; Zhang K; Yin G; Liu Y
Eur J Dermatol; 2007; 17(5):392-6. PubMed ID: 17673382
[TBL] [Abstract][Full Text] [Related]
11. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids.
Mussi A; Bonifati C; Carducci M; Viola M; Tomaselli R; Sacerdoti G; Fazio M; Ameglio F
J Biol Regul Homeost Agents; 1994; 8(4):117-20. PubMed ID: 7660853
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis.
He Z; Jin L; Liu ZF; Hu L; Dang EL; Feng ZZ; Li QJ; Wang G
Br J Dermatol; 2012 Jul; 167(1):191-3. PubMed ID: 22356196
[TBL] [Abstract][Full Text] [Related]
13. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
14. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum.
Murakami M; Hagforsen E; Morhenn V; Ishida-Yamamoto A; Iizuka H
Exp Dermatol; 2011 Oct; 20(10):845-7. PubMed ID: 21732985
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder.
Zhang K; Li X; Yin G; Liu Y; Niu X; Hou R
Br J Dermatol; 2008 Feb; 158(2):298-305. PubMed ID: 18070209
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of parathyroid hormone and parathyroid-related peptide in psoriasis.
Regaña MS; Ezquerra GM; Millet PU
Acta Derm Venereol; 2005; 85(5):420-3. PubMed ID: 16159734
[TBL] [Abstract][Full Text] [Related]
17. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis.
Li HH; Lin YC; Chen PJ; Hsiao CH; Lee JY; Chen WC; Tzung TY; Wu JC; Chang MS
Br J Dermatol; 2005 Sep; 153(3):591-5. PubMed ID: 16120148
[TBL] [Abstract][Full Text] [Related]
19. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 4 plasma levels in psoriasis vulgaris patients.
Zalewska A; Wyczółkowska J; Dziankowska-Bartkowiak B; Sysa-Jedrzejowska A
Med Sci Monit; 2004 Apr; 10(4):CR156-62. PubMed ID: 15039646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
